Sporicidin product clearances
This article was originally published in The Gray Sheet
On Feb. 12, agency clears Sporicidin's three disinfectant products (a spray, a solution and towellettes) for marketing as "intermediate level" disinfectants, FDA says in a Feb. 12 "Talk Paper." The company's cold sterilizing solution and Sporicidin HD solution have not yet been cleared. "In order to get clearance, the firm must submit data showing that they are safe and effective," according to the agency. After participating in a government seizure of Sporicidin's products in December 1991, FDA reached a consent decree with the company in May 1992 ("The Gray Sheet" May 18, In Brief).
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.